Study Identifies “Lethal” Subtype of Prostate Cancer
March 16, 2015 · No comments
Of prostate cancer patients with combination MAP3K7 and CHD1 deletions, about 50 percent will have recurrent prostate cancer.
Quick Antibiotics for Fever and Low Neutrophil Count Reduces PICU Needs and Mortality of Pediatric Cancer Patients
February 25, 2015 · Comments Off
Changes help Children's Hospital Colorado reduce time-to-delivery of antibiotics in pediatric cancer patients with fever and neutropenia from 150 minutes to 46 minutes.
In Triple-Negative Breast Cancer, Even Low-Androgen Tumors Respond to Anti-Androgen Therapy
February 24, 2015 · Comments Off
Valerie Barton, PhD candidate in the lab of CU Cancer Center researcher, Jennifer Richer, PhD, shows that even triple negative breast cancers with few androgen receptors respond to anti-androgen therapy.
SCIENCE: Cancerous Chromosome “Bumper” Repair Depends on More than Mutation in Bladder Cancer
February 17, 2015 · Comments Off
Like a car's bumper, telomeres protect chromosomes. CU Cancer Center study in SCIENCE shows that improper repair can cause cancer.
Study Pinpoints How RhoGDI2 Suppresses Bladder Cancer Metastasis
February 12, 2015 · Comments Off
Discovery that RhoGDI2 blocks action of RhoC to suppress tumors may finally provide a druggable target allowing researchers to manipulate this signaling in a way that reduces tumor metastasis.
Study: Young Adult Survivors Most Distressed After Leukemia and Lymphoma Treatment
February 11, 2015 · Comments Off
"Now that patients are living longer with cancer and after cancer, it is becoming more and more important to look at how survivors are living. What is their quality of life and how can we help make it better?" says Whitney Jones, PhD.
Genes Altered in Adult Cancer Found in Young-Adult Bone Cancer, Ewing Sarcoma
February 3, 2015 · Comments Off
A University of Colorado Cancer Center study published in the journal PLoS One finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, potentially offering ways to improve therapy.
Whose Numbers Should We Use to Calculate the Cost-Effectiveness of Targeted Anti-Cancer Therapies?
February 2, 2015 · Comments Off
"If we don’t address the feasibility of actually delivering these breakthroughs to patients in the real world they will not be breakthroughs at all," write Camidge and Atherly.
Phase 1 Clinical Trial of CUDC-101 “Throws Kitchen Sink” at Head and Neck Cancer
January 26, 2015 · Comments Off
Clinical Trial of CUCD-101 shows activity against drivers of head and neck cancer, EGFR, Her2 and HDAC
Bitter melon juice prevents pancreatic cancer in mouse models
January 26, 2015
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Remember! "Cancer: The Emperor of All Maladies" starts tonight at 8. You will not want to miss this! ow.ly/KZ956